Correction to: Risk prediction of hepatobiliary and pancreatic cancersin elderly Chinese: The Dongfeng-Tongji cohort

IF 3.6 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Journal of Evidence‐Based Medicine Pub Date : 2024-01-12 DOI:10.1111/jebm.12580
{"title":"Correction to: Risk prediction of hepatobiliary and pancreatic cancersin elderly Chinese: The Dongfeng-Tongji cohort","authors":"","doi":"10.1111/jebm.12580","DOIUrl":null,"url":null,"abstract":"<p>Lyu J, Guan X, Zhou Y, Guo H, Cheng S, Wang C. Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng-Tongji cohort. J Evid Based Med. 2023; 16:39-49.</p><p>1. In Supplementary Figure l, the unit in “Diagnosis of pancreatic or hepatobiliary cancer in &lt; 3 or &gt; 70 weeks of follow-up” was incorrect. The unit “weeks” should be changed to “months.”</p><p>2. In the second last paragraph of the Results section, the text “and even lower for PC (0.21%, 95% CI (0.13%, 0.28%)) and PPV (67.63%, 95% CI (67.19%, 68.07%) specificity, Table 3)” should be modified to “and even lower for PC (0.21% (0.13-0.28%) PPV and 67.63% (67.19-68.07%) specificity, Table 3).”</p><p>3. In the second paragraph of the Discussion section, three numbers of AUC were incorrect. The number 0.828 on line 6 should be 0.818. The number 0.862 on line 12 should be 0.843. The number 0.890 on line 13 should be 0.873.</p><p>We apologize for these errors, which were introduced unintentionally during the revision (1 and 3) and the production process (2). The correction does not change any results and conclusions of the article.</p>","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jebm.12580","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Evidence‐Based Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jebm.12580","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Lyu J, Guan X, Zhou Y, Guo H, Cheng S, Wang C. Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng-Tongji cohort. J Evid Based Med. 2023; 16:39-49.

1. In Supplementary Figure l, the unit in “Diagnosis of pancreatic or hepatobiliary cancer in < 3 or > 70 weeks of follow-up” was incorrect. The unit “weeks” should be changed to “months.”

2. In the second last paragraph of the Results section, the text “and even lower for PC (0.21%, 95% CI (0.13%, 0.28%)) and PPV (67.63%, 95% CI (67.19%, 68.07%) specificity, Table 3)” should be modified to “and even lower for PC (0.21% (0.13-0.28%) PPV and 67.63% (67.19-68.07%) specificity, Table 3).”

3. In the second paragraph of the Discussion section, three numbers of AUC were incorrect. The number 0.828 on line 6 should be 0.818. The number 0.862 on line 12 should be 0.843. The number 0.890 on line 13 should be 0.873.

We apologize for these errors, which were introduced unintentionally during the revision (1 and 3) and the production process (2). The correction does not change any results and conclusions of the article.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
更正:中国老年人肝胆胰癌的风险预测:东风-同济队列。
Lyu J, Guan X, Zhou Y, Guo H, Cheng S, Wang C. 中国老年人肝胆胰癌的风险预测:东风-同济队列。J Evid Based Med.2023; 16:39-49.1.在补充图l中,"随访3周或70周诊断为胰腺癌或肝胆癌 "中的单位不正确。单位 "周 "应改为 "月"。结果部分倒数第二段中,"PC(0.21%,95% CI (0.13%, 0.28%))和 PPV(67.63%,95% CI (67.19%, 68.07%) 特异性,表 3)"应改为 "PC(0.21%,95% CI (0.13%, 0.28%))和 PPV(67.63%,95% CI (67.19%, 68.07%) 特异性,表 3)"。21% (0.13-0.28%) PPV 和 67.63% (67.19-68.07%) 特异性,表 3)"。 3.讨论部分第二段中,AUC 的三个数字不正确。第 6 行的数字 0.828 应为 0.818。第 12 行的数字 0.862 应为 0.843。第 13 行的数字 0.890 应为 0.873。我们对这些错误表示歉意,这些错误是在修订(1 和 3)和生产过程(2)中无意引入的。更正并不改变文章的任何结果和结论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Evidence‐Based Medicine
Journal of Evidence‐Based Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
11.20
自引率
1.40%
发文量
42
期刊介绍: The Journal of Evidence-Based Medicine (EMB) is an esteemed international healthcare and medical decision-making journal, dedicated to publishing groundbreaking research outcomes in evidence-based decision-making, research, practice, and education. Serving as the official English-language journal of the Cochrane China Centre and West China Hospital of Sichuan University, we eagerly welcome editorials, commentaries, and systematic reviews encompassing various topics such as clinical trials, policy, drug and patient safety, education, and knowledge translation.
期刊最新文献
Evaluation and management of knee osteoarthritis. Issue Information Diagnosis and management of inflammatory bowel disease The Guidelines for use and promotion of low sodium salt in China The ethics of some placebo-controlled randomized controlled trials
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1